Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
XORTX Therapeutics
(NASDAQ:XRTX)
Intraday
$2.62
0.10
[3.97%]
After-Hours
$2.62
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$2.62
0.10
[3.97%]
At close: May 10
$2.62
0
[0.00%]
PreMarket: 4:16PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for XORTX Therapeutics Stock (NASDAQ:XRTX)
XORTX Therapeutics Stock (NASDAQ: XRTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, March 18, 2024
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 18, 2024, 2:37PM
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 6, 2024, 1:54PM
Tuesday, March 05, 2024
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 5, 2024, 1:11PM
Monday, March 04, 2024
XORTX Finalized $2.7M Prospectus Supplement and Concurrent Private Placement for the Offering of Units
Charles Gross
-
Mar 4, 2024, 7:21AM
Thursday, January 04, 2024
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Jan 4, 2024, 1:37PM
XORTX Therapeutics shares are trading higher after Alliance Global Partners maintained a Buy rating on the stock and raised its price target from $9 to $14.
Benzinga Newsdesk
-
Jan 4, 2024, 11:30AM
Alliance Global Partners Maintains Buy on XORTX Therapeutics, Raises Price Target to $14
Benzinga Newsdesk
-
Jan 4, 2024, 9:09AM
Thursday, November 30, 2023
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 30, 2023, 1:13PM
Thursday, November 09, 2023
XORTX Therapeutics shares are trading lower. The company announced a 1-for-9 share consolidation.
Benzinga Newsdesk
-
Nov 9, 2023, 2:19PM
Wednesday, November 08, 2023
XORTX Therapeutics Announces 1-For-9 Share Consolidation
Benzinga Newsdesk
-
Nov 8, 2023, 5:54PM
Tuesday, October 24, 2023
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 24, 2023, 2:12PM
Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 24, 2023, 7:31AM
Monday, October 23, 2023
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 23, 2023, 1:54PM
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
Lisa Levin
-
Oct 23, 2023, 9:43AM
Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 23, 2023, 7:32AM
Friday, October 20, 2023
Why Adial Pharmaceuticals Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 20, 2023, 1:45PM
What's Going On With Xortx Therapeautics Stock?
Erica Kollmann
-
Oct 20, 2023, 11:33AM
Dow Falls 50 Points; American Express Earnings Top Views
Lisa Levin
-
Oct 20, 2023, 9:43AM
Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 20, 2023, 7:42AM
Monday, October 09, 2023
Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket
Lisa Levin
-
Oct 9, 2023, 8:20AM
Friday, October 06, 2023
Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 6, 2023, 1:59PM
Why Pioneer Natural Resources Shares Are Bouncing By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 6, 2023, 8:26AM
Thursday, October 05, 2023
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 5, 2023, 1:22PM
Thursday, April 20, 2023
XORTX Therapeutics Inc. Gets FDA Orphan Drug Designation For Oxypurinol For Treatment Of Autosomal Dominant Polycystic Kidney Disease
Benzinga Newsdesk
-
Apr 20, 2023, 11:48AM
Monday, April 03, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Apr 3, 2023, 1:36PM
Tuesday, March 14, 2023
Xortx Announced Type D Meeting With FDA To Be Held May 1, 2023
Charles Gross
-
Mar 14, 2023, 7:07AM
Wednesday, February 01, 2023
XORTX Announced Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease
Charles Gross
-
Feb 1, 2023, 7:05AM
Friday, January 27, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Jan 27, 2023, 12:26PM
Xortx Therapeutics Inc Filed For Mixed Shelf Of Up To $50M
Charles Gross
-
Jan 27, 2023, 6:50AM
Friday, January 20, 2023
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Jan 20, 2023, 1:24PM
Thursday, January 19, 2023
Dow Drops 150 Points; Crude Oil Up 1%
Lisa Levin
-
Jan 19, 2023, 2:54PM
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Jan 19, 2023, 1:33PM
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
Lisa Levin
-
Jan 19, 2023, 12:00PM
XORTX Therapeutics shares are trading higher after the company announced topline results from the XRX-OXY-101 clinical trial.
Benzinga Newsdesk
-
Jan 19, 2023, 8:45AM
XORTX Shares Jump After Encouraging Data From Pharmacokinetics Study Of Formulated Oral Oxypurinol
Vandana Singh
-
Jan 19, 2023, 8:15AM
XORTX Announces Topline Results From XRX-OXY-101 Clinical Trial
Bill Haddad
-
Jan 19, 2023, 7:07AM
Wednesday, December 28, 2022
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Dec 28, 2022, 1:00PM
Monday, December 19, 2022
XORTX Announces Completion Of Dosing In XRX-OXY-101 Clinical Study
Benzinga Newsdesk
-
Dec 19, 2022, 7:10AM
Monday, November 28, 2022
XORTX Announces Completion Of Screening And Enrollment In Bridging Pharmacokinetics Study
Benzinga Newsdesk
-
Nov 28, 2022, 7:01AM
Friday, October 28, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Oct 28, 2022, 12:12PM
Wednesday, October 26, 2022
XORTX Receives Further No Objection Letter From Health Canada
Benzinga Newsdesk
-
Oct 26, 2022, 7:08AM
Tuesday, October 04, 2022
XTORTX Therapeutics shares are trading lower after the company announced a $5 million public offering.
Benzinga Newsdesk
-
Oct 4, 2022, 8:55AM
XORTX Announces $5M Public Offering
Bill Haddad
-
Oct 4, 2022, 8:31AM
Monday, September 26, 2022
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Lisa Levin
-
Sep 26, 2022, 3:43AM
Friday, September 23, 2022
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Sep 23, 2022, 12:16PM
Thursday, September 22, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 22, 2022, 2:17PM
Thursday, August 25, 2022
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
Lisa Levin
-
Aug 25, 2022, 5:18AM
Wednesday, August 24, 2022
Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Aug 24, 2022, 12:32PM
Monday, August 22, 2022
Why XORTX Therapeutics Stock Is Rising Today
Adam Eckert
-
Aug 22, 2022, 10:22AM
XORTX Therapeutics shares are trading higher after the company announced positive results from its pharmacokinetics bridging study.
Benzinga Newsdesk
-
Aug 22, 2022, 8:06AM
Show more